266 related articles for article (PubMed ID: 19708688)
1. Kinetics and activation parameters for oxidations of styrene by Compounds I from the cytochrome P450(BM-3) (CYP102A1) heme domain and from CYP119.
Yuan X; Wang Q; Horner JH; Sheng X; Newcomb M
Biochemistry; 2009 Sep; 48(38):9140-6. PubMed ID: 19708688
[TBL] [Abstract][Full Text] [Related]
2. Hole Hopping through Tryptophan in Cytochrome P450.
Ener ME; Gray HB; Winkler JR
Biochemistry; 2017 Jul; 56(28):3531-3538. PubMed ID: 28689401
[TBL] [Abstract][Full Text] [Related]
3. Spectra and kinetic studies of the compound I derivative of cytochrome P450 119.
Sheng X; Horner JH; Newcomb M
J Am Chem Soc; 2008 Oct; 130(40):13310-20. PubMed ID: 18788736
[TBL] [Abstract][Full Text] [Related]
4. Quantitative production of compound I from a cytochrome P450 enzyme at low temperatures. Kinetics, activation parameters, and kinetic isotope effects for oxidation of benzyl alcohol.
Wang Q; Sheng X; Horner JH; Newcomb M
J Am Chem Soc; 2009 Aug; 131(30):10629-36. PubMed ID: 19572732
[TBL] [Abstract][Full Text] [Related]
5. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
6. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
7. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of oxidation of benzphetamine by compounds I of cytochrome P450 2B4 and its mutants.
Sheng X; Zhang H; Im SC; Horner JH; Waskell L; Hollenberg PF; Newcomb M
J Am Chem Soc; 2009 Mar; 131(8):2971-6. PubMed ID: 19209859
[TBL] [Abstract][Full Text] [Related]
9. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
10. Development of an improved Amplex Red peroxidation activity assay for screening cytochrome P450 variants and identification of a novel mutant of the thermophilic CYP119.
Başlar MS; Sakallı T; Güralp G; Kestevur Doğru E; Haklı E; Surmeli NB
J Biol Inorg Chem; 2020 Oct; 25(7):949-962. PubMed ID: 32924072
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of 10-undecenoic acid by cytochrome P450(BM-3) and its Compound I transient.
Chen X; Su Z; Horner JH; Newcomb M
Org Biomol Chem; 2011 Nov; 9(21):7427-33. PubMed ID: 21901220
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM reveals the architecture of the dimeric cytochrome P450 CYP102A1 enzyme and conformational changes required for redox partner recognition.
Su M; Chakraborty S; Osawa Y; Zhang H
J Biol Chem; 2020 Feb; 295(6):1637-1645. PubMed ID: 31901079
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome p450 compound I.
Newcomb M; Zhang R; Chandrasena RE; Halgrimson JA; Horner JH; Makris TM; Sligar SG
J Am Chem Soc; 2006 Apr; 128(14):4580-1. PubMed ID: 16594688
[TBL] [Abstract][Full Text] [Related]
14. Regioselective oxidation of lauric acid by CYP119, an orphan cytochrome P450 from Sulfolobus acidocaldarius.
Lim YR; Eun CY; Park HG; Han S; Han JS; Cho KS; Chun YJ; Kim D
J Microbiol Biotechnol; 2010 Mar; 20(3):574-8. PubMed ID: 20372030
[TBL] [Abstract][Full Text] [Related]
15. Glutamate-haem ester bond formation is disfavoured in flavocytochrome P450 BM3: characterization of glutamate substitution mutants at the haem site of P450 BM3.
Girvan HM; Levy CW; Williams P; Fisher K; Cheesman MR; Rigby SE; Leys D; Munro AW
Biochem J; 2010 Apr; 427(3):455-66. PubMed ID: 20180779
[TBL] [Abstract][Full Text] [Related]
16. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
[TBL] [Abstract][Full Text] [Related]
17. Photooxidation of cytochrome P450-BM3.
Ener ME; Lee YT; Winkler JR; Gray HB; Cheruzel L
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18783-6. PubMed ID: 20947800
[TBL] [Abstract][Full Text] [Related]
18. A highly active single-mutation variant of P450BM3 (CYP102A1).
Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
[TBL] [Abstract][Full Text] [Related]
19. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7.
Chen CK; Berry RE; Shokhireva TKh; Murataliev MB; Zhang H; Walker FA
J Biol Inorg Chem; 2010 Feb; 15(2):159-74. PubMed ID: 19727859
[TBL] [Abstract][Full Text] [Related]
20. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
